Depression and cigarette smoking independently relate to reduced health-related quality of life among Canadians living with hepatitis C

Canadian Journal of Gastroenterology

Volumn 20, Issue 2, 2006, Pages 81-86

  Balfour, Louise ^a,b,c   Cooper, Curtis ^a,b,c   Kowal, John ^a,b   Tasca, Giorgio A ^b,c,d   Silverman, Amy ^a   Kane, Marie ^a   Garber, Gary ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d CARLETON UNIVERSITY   (Canada)

Author keywords

Cigarette smoking; Depression; Health related quality of life; Hepatitis C

Indexed keywords

VIRUS RNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANADA; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHRONIC HEPATITIS; CIGARETTE SMOKING; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; SMOKING CESSATION; STUDENT T TEST; UNITED STATES;

EID: 33645312059     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/469761     Document Type: Article

References (43)

1. Chong CA, Gulamhussein A, Heathcote EJ, et al. Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol 2003;98:630-8.
2. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002;35:433-9.
3. Cordoba J, Flavia M, Jacas C, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003;39:231-8.
4. Vogt MT, Hanscom B, Lauerman WC, Kang JD. Influence of smoking on the health status of spinal patients: The National Spine Network database. Spine 2002;27:313-9.
5. Olufade AO, Shaw JW, Foster SA, Leischow SJ, Hays RD, Coons SJ. Development of the smoking cessation quality of life questionnaire. Clin Ther 1999;21:2113-30.
6. Wang CS, Wang ST, Chang TT, Yao WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: Implications for prevention of hepatitis C virus progression. Arch Intern Med 2002;162:811-5.
7. Kuper H, Tzonou A, Kaklamani E, et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000;85:498-502.
8. Mukaiya M, Nishi M, Miyake H, Hiram K. Chronic liver diseases for the risk of hepatocellular carcinoma: A case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology 1998;45:2328-32.
9. Hezode C, Lonjon I, Roudot-Thoraval F et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 2003;52:126-9.
10. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. Am J Psychiatry 2000;157:867-76.
11. Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WL. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychsom Res 2000;49:311-7.
12. Borraccorso S, Puzella A, Marino V, et al. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 2001; 105:45-55.
13. Daniel M, Cargo MD, Lifshay J, Green LW. Cigarette smoking, mental health and social support: Data from a northwestern First Nation.Can J Public Health 2004;95:45-9.
14. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA 2000;284:2606-10.
15. Duffy SA, Terrell JE, Valenstein M, Ronis DL, Copeland LA, Connors M. Effect of smoking, alcohol, and depression on the quality of life of head and neck cancer patients. Gen Hosp Psychiatry 2002;24:140-7.
16. Haire-Joshu D, Heady S, Thomas L, Schechtman K, Fisher EB Jr. Depressive symptomatology and smoking among persons with diabetes. Res Nuts Health 1994;17:273-82.
17. Ware JE, Snow KK, Kosisnki M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, 1993.
18. Hopman WM, Towheed T, Anastassiades T, et al. Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ 2000;163:265-71.
19. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
20. Schroevers MJ, Sanderman, R, van Sonderen E, Ranchor AV. The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: Depressed and Positive Affect in cancer patients and healthy reference subjects. Qual Life Res 2000;9:1015-29.
21. Ware JE Jr. SF-36 health survey update. Spine 2000;25:3130-9.
22. Kennedy SH, Eisfeld BS, Cooke RG. Quality of life: An important dimension in assessing the treatment of depression? J Psychiatry Neurosci 2001;26(Suppl):S23-8.
23. Kraus MR, Schafer A, Csef H, Scheurlen M, Faller, H. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics 2000;41:377-84,
24. Halman M. Management of depression and related neuropsychiatric symptoms associated with HIV/AIDS and antiretroviral therapy. Can J Infect Dis 2001;12(Suppl C):9C-19C.
25. Health Canada. Canadian tobacco use monitoring survey (CTUMS): Prevalence 2000-2002. (Version current at January 19, 2006).
26. Hauser W, Zimmer C, Schiedermaier P, Grandt D. Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C. Psychosom Med 2004;66:954-8.
27. Pessione F, Ramond MJ, Njapoum C, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001;34:121-5.
28. Sladden TJ, Hickey AR, Dunn TM, Beard JR. Hepatitis C virus infection: Impacts on behaviour and lifestyle. Aust N Z J Public Health 1998;22:509-11.
29. Sun CA, Wu DM, Lin CC, et al. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: A prospective study of 12,008 men in Taiwan. Am J Epidermiol 2003;157:674-82.
30. Fisher EB Jr, Haire-Joshu D, Morgan GD, Rehberg H, Rost K. Smoking and smoking cessation. Am Rev Respir Dis 1990; 142:702-20.
31. Hashibe M, Ford DE, Zhang ZF Marijuana smoking and head and neck cancer. J Clin Pharmacol 2002;42(11 Suppl):103S-7S.
32. Carvajal Garcia-Pando A, Garcia del Pozo J, Sanchez AS, Velasco MA, Rueda de Castro AM, Lucena MI. Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry 2002;63:135-7.
33. Gleason CC, Yates WR, Isbell MD, Philipsen MA. An open-label trial of citalopram for major depression in patients with hepatitis C. J Clin Psychiatry 2002;63:194-8.
34. Jarrett RB, Rush AJ. Short-term psychotherapy of depressive disorders: Current status and future directions. Psychiatry 1994;57:115-32.
35. Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. Quality of life assessments in major depressive disorder: A review of the literature. Gen Hosp Psychiatry 2004;26:13-7.
36. Judd LL, Akiskal HS, Zeller PJ, et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000;57:375-80.
37. Kruijshaar ME, Hoeymans N, Bijl RV, Spijker J, Essink-Bot ML. Levels of disability in major depression: Findings from the Netherlands mental health survey and incidence study (NEMESIS). J Affect Disord 2003;77:53-64.
38. McHutchison JG, Ware JE Jr, Bayliss MS, et al. The effects of interferon alpha-2b in combination with ribavirin on health-related quality of life and work productivity. J Hepatol 2001;34:140-7.
39. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), 4th edn. Washington: American Psychiatric Publishing, 2000.
40. First MB, Spitzer RL, Gibbon M, Williams JBW Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version. New York: Biometric Research, New York State Psychiatric Institute, 2002.
41. Taira DA, Seto TB, Ho KK, et al. Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation 2000;102:1369-74.
42. Rahkonen O, Laaksonen M, Karvonens. The contribution of lone parent-hood and economic difficulties to smoking. Soc Sci Med 2005;61:211-6.
43. Siahpush M, Borland R. Socio-demographic variations in smoking status among Australians aged > or = 18: Multivariate results from the 1995 National Health Survey. Aust N Z J Public Health 2001;25:438-42.